• Review Articles and Commentaries

Validation of Treatment Effect, Clinical Studies (n=117 total, 54 cohorts)

University of Turku, Lesion-Targeted Ablation with Prostatectomy at 3 Weeks (n=6)

Sunnybrook Hospital, First-in-Man Treat-and-Resect Studies (n=13, 2 cohorts)

CAUTION: Products shown may not be approved for sale in all jurisdictions. Rx only device.
Contact us at info@profoundmedical.com for more information regarding the regulatory status of the device.

106734B